Publication | Closed Access

Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1

InflammationRheumatologyNanomedicineAnti-inflammatoryNanotherapeuticsTherapeutic NanomaterialsMedicineImmunologyDrug Delivery SystemsNano-drug DeliveryPharmacologyInflammatory ArthritisRheumatoid Arthritis